EULAR 2025 | ABSTRACTS
EULAR invites you to submit an abstract to EULAR 2025, the European Congress of Rheumatology.
Submission opens: 1 October 2024
Submission Deadline: 15 January 2025
Every year EULAR invites abstract submitters from all over the globe to present their work at the European Congress of Rheumatology. In 2025, we will host a Congress with a fully onsite programme.
Our abstract topic chairs and reviewers assess all submitted abstracts and case reports, before inviting the presenting authors to show their work as Oral Abstracts, Poster Tours and Posters onsite in Barcelona.
IMPORTANT NOTES
- Abstracts can only be submitted online.
- We discourage splitting data from one study into several abstracts (“salami-slicing”) unless the amount of data cannot be condensed into a single abstract. In the submission forms, authors must indicate whether there are several abstracts related to a single study.
- Abstracts should not be submitted if the following applies:
- the abstract has been published or accepted for publication in a print or online journal before the abstract deadline (15 January 2025). Publication of the abstract in a scientific journal after the submission deadline is not in conflict with presenting it at EULAR congress 2025.
- the abstract was presented at a scientific meeting more than 12 months prior to EULAR 2025.
Presentation of an abstract or information thereof at another conference between 1 September 2025 and acceptance notification of the abstract for EULAR 2025 (week of 24 March 2025) is possible. This must be indicated on the abstract submission form.
- Abstracts accepted for the congress are subject to the EULAR Embargo rules. With the submission of an abstract, the authors agree to the embargo rules.
- Submissions from Russia and Belarus-based institutions or authors will not be accepted.
REVIEW
- Abstracts are reviewed blindly. The reviewers will judge the abstracts according to the scientific or clinical value, relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
- Abstract acceptance will be in one of four categories:
- Oral presentation
- Poster tour presentation
- Poster view
- Publication only
- Licence agreement: The authors, represented by the presenting author, will have to sign an agreement to grant EULAR the right to use the entire presentation (slides, video and audio recording during the conference) during the congress and subsequently for (paid or unpaid) educational purposes.
- Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision regarding acceptance of an abstract will be taken by the EULAR Scientific Programme Committee. EULAR does not communicate, nor enter into correspondence on the reasons for acceptance or rejection of an abstract.
ACCEPTANCE
- Accepted abstracts will be published in a supplement to the Annals of Rheumatic Diseases (ARD). Information on accepted abstracts (title and authors) will also be available in the online programme approximately two weeks prior to the congress. Published abstracts will be available in the EULAR Abstract Archive during and after the congress.
- Case reports will not be added in the ARD and will only be available in the EULAR Abstract Archive.
- The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the EULAR Scientific Programme Committee. We therefore recommend submitters of abstracts to register for the congress at the time of abstract submission.
- If you need to withdraw your abstract, a written statement listing the reasons for this decision must be sent to the abstract help desk at congress.abs@eular.org.
TRAVEL
- Please note that the presenting authors of all accepted abstracts for oral, poster tour and poster view presentations will be required to present physically in Barcelona. If, unexpectedly, the presenting author is unable to attend the congress, they would need to assign a co-author to present the abstract onsite.
- If the presenting author needs a letter of invitation for their visa application, they can apply for this via EULAR congress account once they have completed their congress registration. The registration team will provide them with the letter once requested. If the registration is being organised by a third party, they can request a visa letter of invitation on behalf of the presenting author.
- Failure to be onsite at the assigned day and time of presentation will result with abstract being completely removed from the EULAR Abstract Archive and Abstract Book.
LATE-BREAKING ABSTRACTS
Submission opens: 14 April 2025
Submission Deadline: 27 April 2025
Please check nearer the time for further information.
FAQS
Abstracts are reviewed blindly by 4 independent reviewers. They will score the abstract on its novelty and originality, significance, how clearly the methods and outcomes are describe, and how interesting it is. Review scores are given to the Topic Chair, who has oversight of all scores of submissions in a topic, and they will use these to select which are selected for presentation at the EULAR Congress.
All presentations are to be held on-site, in-person. If no-one can attend to present, your abstract will be removed from the Abstract Book and the Scientific Programme. There is no presentation component of 'Publication Only' abstracts.
No, this is determined by the review outcome and the decision of the Topic Chair. Your submission of the abstract constitutes an agreement to present the work at the Congress (for all outcomes other than 'Publication Only').
Yes, you can submit an abstract that you are not an author on. You will need to select a presenting author from the list of authors when submitting an abstract.
EULAR does accept promissory abstracts, but please be aware that the reviewers will review the abstract in the context of what is provided. Please note that a later submission will open for the 'Late-Breaking Abstracts' which can be used to submit work where the data were not available by the regular submission (this will incur a charge of 100€).
No; whilst QR codes are permitted on presentations, we do not allow these for the abstracts themselves. If a QR code is found on an abstract, it will be rejected.
Please refer to the embargo policy.